Abstract:INTRODUCTION: Each wave of the COVID-19 pandemic exhibited a unique combination of epidemiological, social and structural characteristics. We explore similarities and differences in wave-over-wave characteristics of patients hospitalised with COVID-19. METHODS: This was a population-based study in Ontario province, Canada. Patients hospitalised with SARS-CoV-2 between 26 February 2020 and 31 March 2022 were included. An admission was considered related to SARS-CoV-2 infection if the provincial inpatient or outpatient hospital databases contained the ICD-10 diagnostic codes U071/U072 or the Ontario Laboratories Information System indicated a positive SARS-CoV-2 test result (PCR or rapid antigen testing) during the admission or up to two weeks prior. The primary outcome was 90-day mortality (modified Poisson regression). Secondary outcomes were use of critical care during the admission (logistic regression) and total length-of-stay (linear regression with heteroskedastic-consistent standard-error estimators). All models were adjusted for demographic characteristics, neighbourhood socioeconomic factors and indicators of illness severity. RESULTS: There were 73,201 SARS-CoV-2-related admissions: 6127 (8%) during wave 1 (wild-type), 14,371 (20%) during wave 2 (wild-type), 16,653 (23%) during wave 3 (Alpha), 5678 (8%) during wave 4 (Delta) and 30,372 (42%) during wave 5 (Omicron). SARS-CoV-2 was the most responsible diagnosis for 70% of admissions during waves 1–2 and 42% in wave 5. The proportion of admitted patients who were long-term care residents was 18% (n = 1111) during wave 1, decreasing to 10% (n = 1468) in wave 2 and <5% in subsequent waves. During waves 1–3, 46% of all admitted patients resided in a neighbourhood assigned to the highest ethnic diversity quintile, which declined to 27% during waves 4–5. Compared to wave 1, 90-day mortality was similar during wave 2 (adjusted risk ratio [aRR]: 1.00 [95% CI: 0.95–1.04]), but lower during wave 3 (aRR: 0.89 [0.85–0.94]), wave 4 (aRR: 0.85 [0.79–0.91]) and wave 5 (aRR: 0.83 [0.80–0.88]). Improvements in survival over waves were observed among elderly patients (p-interaction <0.0001). Critical care admission was significantly less likely during wave 5 than previous waves (adjusted odds ratio: 0.50 [0.47–0.54]). The length of stay was a median of 8.5 (3.6–23.8) days during wave 1 and 5.3 (2.2–12.6) during wave 5. After adjustment, the mean length of stay was on average –10.4 (–11.1 to –9.8) days, i.e. shorter, in wave 5 vs wave 1. CONCLUSION: Throughout the pandemic, sociodemographic characteristics of patients hospitalised with SARS-CoV-2 changed over time, particularly in terms of ethnic diversity, but still disproportionately affected patients from more marginalised regions. Improved survival and reduced use of critical care during the Omicron wave are reassuring.

Morbidity and Mortality of Hospitalised Patients with Candidemia During the Various Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Waves: A Multicentre Evaluation of 248 US Hospitals.

Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis

Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients

Epidemiological Assessment and Risk Factors for Mortality of Bloodstream Infections by Candida sp. and the Impact of the COVID-19 Pandemic Era

Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID‐19‐associated candidemia

Candidemia Following Severe COVID‐19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta‐Analysis

Clinical Features and Prognostic Risk Factors of Candidemia in Non-Intensive Care Unit Wards

Candidaemia and Central Line-Associated Candidaemia in a Network of Indian ICUs: Impact of COVID-19 Pandemic

Mortality in hospitalized SARS-CoV-2 patients with contemporaneous bacterial and fungal infections

Changing Epidemiology of Clinical Isolates of Candida Species during the Coronavirus Disease 2019 Pandemic: Data Analysis from a Korean Tertiary Care Hospital for 6 Years (2017–2022)

Candida Isolation During COVID-19: Microbiological Findings of a Prospective Study in a Regional Hospital

Epidemiology, Species Distribution, Antifungal Susceptibility and Mortality Risk Factors of Candidemia among Critically Ill Patients: a Retrospective Study from 2011 to 2017 in a Teaching Hospital in China

[Analysis of Clinical Characteristics and Risk Factors Associated with Prognosis of Patients with Candidemia].

Role of source control in critically ill candidemic patients: a multicenter retrospective study

Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023

Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes

Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients

Epidemiology, risk factors, treatment and outcome of Candida bloodstream infections because of Candida albicans and Candida non‐albicans in two district general hospitals in the United Kingdom

Analysis of risk factors and prognosis of patients with candidemia

A cohort study of patients hospitalised with SARS-CoV-2 infection in Ontario: patient characteristics and outcomes by wave

Pathogen Species Is Associated With Mortality in Nosocomial Bloodstream Infection in Patients With COVID-19